Hypermarcas (OTCMKTS:HYPMY) Announces Earnings Results

Hypermarcas (OTCMKTS:HYPMY) announced its earnings results on Thursday. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.13 by $0.01, Zacks reports. Hypermarcas had a net margin of 19.77% and a return on equity of 14.63%.

Hypermarcas Trading Up 2.2%

OTCMKTS HYPMY traded up $0.09 during trading on Friday, reaching $4.22. The company’s stock had a trading volume of 68,435 shares, compared to its average volume of 7,582. The stock has a market capitalization of $2.97 billion, a PE ratio of 8.44 and a beta of 0.70. Hypermarcas has a 1-year low of $3.71 and a 1-year high of $5.50. The business has a 50-day moving average price of $4.09 and a 200-day moving average price of $4.36.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. Zacks Research raised Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy”.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.